Search research articles
Contact Us
Filters
Showing results (171-180 of 297) with videos related to
Page
of 30
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 21, 2020
Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
Kenneth H Risner, Katie V Tieu, Yafei Wang, et al.
Pulmonary Circulation
|
July 10, 2023
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository
Harrison W Farber, Murali M Chakinala, Michelle Cho, et al.
BMC Pulmonary Medicine
|
May 10, 2025
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey
Ho Cheol Kim, Christopher S King, Christopher Thomas, et al.
Pulmonary Circulation
|
April 24, 2023
Prevalence of pulmonary hypertension in patients with COVID-19 related lung disease listed for lung transplantation: A UNOS registry analysis
Christopher Thomas, Abhimanyu Chandel, Christopher S King, et al.
ERJ Open Research
|
May 25, 2023
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis
Abhimanyu Chandel, Christopher S King, Rosalinda V Ignacio, et al.
Respiratory Research
|
November 11, 2022
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
Toby M Maher, Courtney Schiffman, Michael Kreuter, et al.
Thorax
|
November 18, 2023
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Steven D Nathan, Shilpa Johri, Joanna M Joly, et al.
BMJ Open Respiratory Research
|
August 18, 2018
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
Steven D Nathan, Lisa H Lancaster, Carlo Albera, et al.
Pulmonary Circulation
|
May 17, 2021
Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
Abhimanyu Chandel, Alison Verster, Husna Rahim, et al.
Pulmonary Circulation
|
April 7, 2023
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension
Lucilla Piccari, Brian Allwood, Katerina Antoniou, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 297) with videos related to
Sort By:
Page
of 30
Biorxiv : the Preprint Server for Biology
|
August 21, 2020
Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
Kenneth H Risner, Katie V Tieu, Yafei Wang, et al.
Pulmonary Circulation
|
July 10, 2023
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository
Harrison W Farber, Murali M Chakinala, Michelle Cho, et al.
BMC Pulmonary Medicine
|
May 10, 2025
Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey
Ho Cheol Kim, Christopher S King, Christopher Thomas, et al.
Pulmonary Circulation
|
April 24, 2023
Prevalence of pulmonary hypertension in patients with COVID-19 related lung disease listed for lung transplantation: A UNOS registry analysis
Christopher Thomas, Abhimanyu Chandel, Christopher S King, et al.
ERJ Open Research
|
May 25, 2023
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis
Abhimanyu Chandel, Christopher S King, Rosalinda V Ignacio, et al.
Respiratory Research
|
November 11, 2022
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease
Toby M Maher, Courtney Schiffman, Michael Kreuter, et al.
Thorax
|
November 18, 2023
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality
Steven D Nathan, Shilpa Johri, Joanna M Joly, et al.
BMJ Open Respiratory Research
|
August 18, 2018
Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
Steven D Nathan, Lisa H Lancaster, Carlo Albera, et al.
Pulmonary Circulation
|
May 17, 2021
Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
Abhimanyu Chandel, Alison Verster, Husna Rahim, et al.
Pulmonary Circulation
|
April 7, 2023
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension
Lucilla Piccari, Brian Allwood, Katerina Antoniou, et al.
Page
of 30